Your browser doesn't support javascript.
loading
Correction: M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma.
He, Mingyu; Wang, Yang; Xie, Jiajie; Pu, Jiaying; Shen, Zhihua; Wang, Ao; Li, Tao; Wang, Tong; Li, Guanghui; Liu, Ying; Mei, Zhongting; Ren, Zijing; Wang, Wenbo; Liu, Xiaoyan; Hong, Jinhuan; Liu, Qian; Lei, Hong; He, Xiaoqi; Du, Weijie; Yuan, Ye; Yang, Lei.
Afiliação
  • He M; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • Wang Y; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Xie J; Department of Pharmacy (The University Key Laboratory of Drug Research, Heilongjiang Province), The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Pu J; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
  • Shen Z; Department of Pharmacy (The University Key Laboratory of Drug Research, Heilongjiang Province), The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Wang A; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
  • Li T; Department of Pharmacy (The University Key Laboratory of Drug Research, Heilongjiang Province), The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Wang T; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
  • Li G; Department of Pharmacy (The University Key Laboratory of Drug Research, Heilongjiang Province), The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Liu Y; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
  • Mei Z; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • Ren Z; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Wang W; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • Liu X; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Hong J; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • Liu Q; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Lei H; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • He X; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Du W; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
  • Yuan Y; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
  • Yang L; National Key Laboratory of Frigid Cardiovascular Disease, Harbin, China.
Oncogene ; 43(17): 1316, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38418547
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China